3,264
Views
2
CrossRef citations to date
0
Altmetric
Research Paper

Developing neuropalliative care for sporadic Creutzfeldt-Jakob Disease

ORCID Icon, , , , , & show all
Pages 23-39 | Received 17 Dec 2021, Accepted 10 Feb 2022, Published online: 03 Mar 2022

References

  • Nakatani E, Kanatani Y, Kaneda H, et al. Specific clinical signs and symptoms are predictive of clinical course in sporadic Creutzfeldt−Jakob disease. Eur J Neurol. 2016;23:1455–1462.
  • Creutzfeldt-Jakob disease fact sheet, Last updated May 9, 2018, Accessed on 2018, Accessed on May 9, 2018 May 9, 2018, Accessed on May 9, 2018, Accessed on May 9.
  • Bechtel K, Geschwind MD. Ethics in prion disease. Prog Neurobiol. 2013;110:29–44.
  • McQuain JA, Galicia-Castillo MC, Morris DA. Palliative care issues in Creutzfeldt: jakob Disease #389. J Palliat Med. 2020;23:424–426.
  • Appleby BS, Yobs DR. Symptomatic treatment, care, and support of CJD patients. Handb Clin Neurol. 2018;153:399–408.
  • Paterson RW, Torres-Chae CC, Kuo AL, et al. Differential diagnosis of Jakob-Creutzfeldt disease. Arch Neurol. 2012;69:1578–1582.
  • Ford L, Rudge P, and Robinson K, Collinge J, Gorham M, Mead Set al. The most problematic symptoms of prion disease – an analysis of carer experiences. Int Psychogeriatr. 2019;31(8):1181-1190. doi:10.1017/S1041610218001588.
  • de Vries K, Sque M, Bryan K, et al. Variant Creutzfeldt-Jakob disease: need for mental health and palliative care team collaboration. Int J Palliat Nurs. 2003;9:512–520.
  • Creutzfeldt CJ, Kluger B, Kelly AG, et al. Neuropalliative care: priorities to move the field forward. Neurology. 2018;91:217–226.
  • Robinson MT, Holloway RG. Palliative care in neurology. Mayo Clin Proc. 2017;92:1592–1601.
  • van der Steen JT, Radbruch L, Cmpm H, et al.; European Association for Palliative Care (EAPC). White paper defining optimal palliative care in older people with dementia: a Delphi study and recommendations from the European association for palliative care. Palliat Med. 2014;28:197–209.
  • Bailey B, Aranda S, Quinn K, et al. Creutzfeldt-Jakob disease: extending palliative care nursing knowledge. Int J Palliat Nurs. 2000;6:131–139.
  • Das K, Davis R, Dutoit B, et al. Sporadic Creutzfeldt-Jakob disease: a description of two cases. Int Psychogeriatr. 2012;24:1183–1185.
  • Kranitz FJ, Simpson DM. Using non-pharmacological approaches for CJD patient and family support as provided by the CJD foundation and CJD insight. CNS Neurol Disord Drug Targets. 2009;8:372–379.
  • Geschwind MD. Prion diseases. Continuum (Minneap Minn). 2015;21:1612–1638.
  • Mitchell SL, Teno JM, Kiely DK, et al. The clinical course of advanced dementia. N Engl J Med. 2009;361:1529–1538.
  • Appleby BS, Yobs DR. Symptomatic treatment, care, and support of CJD patients. Handb Clin Neurol. 2018;153:399–408.
  • National Coalition for Hospice and Palliative Care. 2018 . Clinical Practice Guidelines for Quality Palliative Care. 4th ed. Richmond, VA, USA.https://www.nationalcoalitionhpc.org/wp-content/uploads/2020/07/NCHPC-NCPGuidelines_4thED_web_FINAL.pdf
  • Parchi P, Giese A, Capellari S, et al. Classification of sporadic Creutzfeldt-Jakob disease based on molecular and phenotypic analysis of 300 subjects. Ann Neurol. 1999;46:224–233.
  • Collins SJ, Sanchez-Juan P, Masters CL, et al. Determinants of diagnostic investigation sensitivities across the clinical spectrum of sporadic Creutzfeldt-Jakob disease. Brain. 2006;129:2278–2287.
  • Information for funeral and crematory practitioners | creutzfeldt-Jakob disease, classic (CJD) | prion disease | CDC, Last updated September 7, 2021, Accessed on September 7, 2021.
  • Lewis M, Glisic K, Jordan D, et al. OVERVIEW FOR FUNERAL SERVICE PROFESSIONALS. 3.
  • Creutzfeldt-Jakob disease foundation, funeral professionals, Last updated August 23, 2016, Accessed on August 23, 2016.
  • Bernacki RE, Block SD; American College of Physicians High Value Care Task Force. Communication about serious illness care goals: a review and synthesis of best practices. JAMA Intern Med. 2014;174:1994–2003.
  • Creutzfeldt CJ, Robinson MT, Holloway RG. Neurologists as primary palliative care providers. Neurol Clin Pract. 2016;6:40–48.
  • Back A. Mastering communication with seriously Ill patients: balancing honesty with empathy and hope. New York: Cambridge University Pres, Cambridge England; 2009.
  • Mataqi M, Aslanpour Z. Factors influencing palliative care in advanced dementia: a systematic review. BMJ Support Palliat Care. 2020;10:145–156.
  • Senderovich H, Retnasothie S. A systematic review of the integration of palliative care in dementia management. Palliat Support Care. 2020;18:495–506.
  • Bernstein Sideman A, Harrison KL, Garrett SB, et al.; Dementia Palliative Care Writing Group, Ritchie CS. Practices, challenges, and opportunities when addressing the palliative care needs of people living with dementia: specialty memory care provider perspectives. Alzheimers Dement (N Y). 2021;7:e12144.
  • Boyd ND, Naasan G, Harrison KL, et al. Characteristics of people with dementia lost to follow-up from a dementia care center. Int J Geriatr Psychiatry. 2021;37. DOI:10.1002/gps.5628
  • Naasan G, Boyd ND, and Harrison KL, et al. Group G dementia geriatric palliative care writing (2021) Advance directive and POLST documentation in decedents with dementia at a memory care center: the importance of early advanced care planning. Neurol Clin Pract. Feb 2022, 12(1): 4-21. DOI: 10.1212/CPJ.0000000000001123 https://cp.neurology.org/content/12/1/14
  • Rendle KA, Abramson CM, Garrett SB, et al. Beyond exploratory: a tailored framework for designing and assessing qualitative health research. BMJ Open. 2019;9:e030123.
  • Tong A, Sainsbury P, Craig J. Consolidated criteria for reporting qualitative research (COREQ): a 32-item checklist for interviews and focus groups. Int J Qual Health Care. 2007;19:349–357.
  • Takada LT, Kim M-O, Cleveland RW, et al. Genetic prion disease: experience of a rapidly progressive dementia center in the United States and a review of the literature. Am J Med Genet B Neuropsychiatr Genet. 2017;174:36–69.
  • Brown DR, Schmidt B, Kretzschmar HA. Role of microglia and host prion protein in neurotoxicity of a prion protein fragment. Nature. 1996;380:345–347.
  • Lenore K, Meredith W. The mini-mental state examination (MMSE). J Gerontol Nurs. 1999;25:8–9.
  • Morris JC. Clinical dementia rating: a reliable and valid diagnostic and staging measure for dementia of the Alzheimer type. Int Psychogeriatr. 1997;9(1):173–176. discussion 177-178.
  • Yesavage JA, Brink TL, Rose TL, et al. Development and validation of a geriatric depression screening scale: a preliminary report. J Psychiatr Res. 1982;17:37–49.
  • Thompson AGB, Lowe J, Fox Z, et al. The medical research council prion disease rating scale: a new outcome measure for prion disease therapeutic trials developed and validated using systematic observational studies. Brain. 2013;136:1116–1127.
  • Hartigan I. A comparative review of the Katz ADL and the Barthel Index in assessing the activities of daily living of older people. Int J Older People Nurs. 2007;2:204–212.
  • Hermann P, Appleby B, Brandel J-P, et al. Biomarkers and diagnostic guidelines for sporadic Creutzfeldt-Jakob disease. Lancet Neurol. 2021;20:235–246.
  • Kim M-O, Takada LT, Wong K, et al. Genetic PrP prion diseases. Cold Spring Harb Perspect Biol. 2018;10:a033134.
  • Boeije H. A purposeful approach to the constant comparative method in the analysis of qualitative Interviews. Qual Quantity. 2002;36:391–409.
  • Cummings JL, Mega M, Gray K, et al. The Neuropsychiatric Inventory: comprehensive assessment of psychopathology in dementia. Neurology. 1994;44:2308–2314.
  • Forner SA, Takada LT, Bettcher BM, et al. Comparing CSF biomarkers and brain MRI in the diagnosis of sporadic Creutzfeldt-Jakob disease. Neurol Clin Pract. 2015;5:116–125.
  • Baile WF, Buckman R, Lenzi R, et al. SPIKES—A Six-step protocol for delivering bad news: application to the patient with cancer. Oncologist. 2000;5:302–311.
  • Bernacki R, Hutchings M, Vick J, et al. Development of the Serious Illness Care Program: a randomised controlled trial of a palliative care communication intervention. BMJ Open. 2015;5:e009032.
  • Piers R, Albers G, Gilissen J, et al. Advance care planning in dementia: recommendations for healthcare professionals. BMC Palliat Care. 2018;17:88.
  • Possin KL, Merrilees JJ, Dulaney S, et al. Effect of collaborative dementia care via telephone and internet on quality of life, caregiver well-being, and health care use: the care ecosystem randomized clinical trial. JAMA Intern Med. 2019;179:1658.
  • Rosa TD, Possin KL, Bernstein A, et al. Variations in costs of a collaborative care model for dementia. J Am Geriatr Soc. 2019;67:2628–2633.
  • Bernstein A, Merrilees J, Dulaney S, et al. Using care navigation to address caregiver burden in dementia: a qualitative case study analysis. Alzheimers Dement (N Y). 2020;6:e12010.
  • Bernstein A, Harrison KL, Dulaney S, et al. The role of care navigators working with people with dementia and their caregivers. J Alzheimers Dis. 2019;71:45–55.
  • van der Smissen D, Overbeek A, van Dulmen S, et al. The feasibility and effectiveness of web-based advance care planning programs: scoping review. J Med Internet Res. 2020;22:e15578.
  • Sudore RL, Schillinger D, Katen MT, et al. Engaging Diverse English- and Spanish-Speaking Older Adults in Advance Care Planning: the PREPARE Randomized Clinical Trial. JAMA Intern Med. 2018;178:1616.
  • Sudore RL, Boscardin J, Feuz MA, et al. Effect of the PREPARE website vs an easy-to-read advance directive on advance care planning documentation and engagement among veterans: a randomized clinical trial. JAMA Intern Med. 2017;177:1102.
  • Wolff JL, Roter DL, Boyd CM, et al. Patient-Family Agenda Setting for Primary Care Patients with Cognitive Impairment: the SAME Page Trial. J Gen Intern Med. 2018;33:1478–1486.
  • O’Shea B, Martin D, Brennan B, et al. Are we ready to “think ahead”? Acceptability study using an innovative end of life planning tool. Ir Med J. 2014;107:138–140.
  • Mitchell SL, Shaffer ML, Cohen S, et al. An advance care planning video decision support tool for nursing home residents with advanced dementia: a cluster randomized clinical trial. JAMA Intern Med. 2018;178:961–969.